|Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis|
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML van der Kop, ...
JAMA: The Journal of the American Medical Association 308 (3), 247-256, 2012
|Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort|
ME Karim, P Gustafson, J Petkau, Y Zhao, A Shirani, E Kingwell, C Evans, ...
American journal of epidemiology 180 (2), 160-171, 2014
|Beta‐interferon exposure and onset of secondary progressive multiple sclerosis|
T Zhang, A Shirani, Y Zhao, ME Karim, P Gustafson, J Petkau, C Evans, ...
European journal of neurology 22 (6), 990-1000, 2015
|Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment|
A Shirani, Y Zhao, J Petkau, P Gustafson, ME Karim, C Evans, E Kingwell, ...
BioMed research international 2015, 2015
|Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies|
ME Karim, P Gustafson, J Petkau, H Tremlett, ...
American journal of epidemiology 184 (4), 325-335, 2016
|Can we train machine learning methods to outperform the high-dimensional propensity score algorithm?|
ME Karim, M Pang, RW Platt
Epidemiology 29 (2), 191-198, 2018
|Estimating inverse probability weights using super learner when weight‐model specification is unknown in a marginal structural Cox model context|
ME Karim, RW Platt, BeAMS Study Group
Statistics in Medicine 36 (13), 2032-2047, 2017
|Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis|
K Ahmed, T McVeigh, R Cerneviciute, S Mohamed, M Tubassam, M Karim, ...
BMC nephrology 19 (1), 323, 2018
|On the application of statistical learning approaches to construct inverse probability weights in marginal structural cox models: hedging against weight-model misspecification|
ME Karim, J Petkau, P Gustafson, H Tremlett, TBS Group
Communications in Statistics-Simulation and Computation 46 (10), 7668-7697, 2017
|Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study|
A Shirani, Y Zhao, ME Karim, J Petkau, P Gustafson, C Evans, E Kingwell, ...
European Journal of Neurology 21 (6), 835-844, 2014
|Role of nonsteroidal antiinflammatory drugs in the association between osteoarthritis and cardiovascular diseases: A longitudinal study|
M Atiquzzaman, ME Karim, J Kopec, H Wong, AH Anis
Arthritis & Rheumatology 71 (11), 1835-1843, 2019
|Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies|
ME Karim, J Petkau, P Gustafson, RW Platt, H Tremlett, ...
Statistical methods in medical research 27 (6), 1709-1722, 2018
|Long-term benefits and adverse effects of Beta-interferon for multiple sclerosis (BeAMS) study group. Comparison of statistical approaches for dealing with immortal time bias …|
ME Karim, P Gustafson, J Petkau, H Tremlett
Am J Epidemiol 184, 325-35, 2016
|Determinants of antibiotic tailoring in pediatric intensive care: A national survey|
PS Fontela, C Quach, ME Karim, DF Willson, E Gilfoyle, JD McNally, ...
Pediatric Critical Care Medicine 18 (9), e395-e405, 2017
|Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient …|
E Gibbs, ME Karim, J Oger
Clinical Immunology 157 (1), 91-101, 2015
|Interferon beta and long-term disability in multiple sclerosis|
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ...
JAMA neurology 70 (5), 651-653, 2013
|Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study|
P Liu, RR Quinn, ME Karim, A Bello, H Tam-Tham, R Weaver, ...
Cmaj 191 (10), E274-E282, 2019
|OP0190 The role of nsaids in the association between osteoarthritis and cardiovascular diseases: a population-based cohort study|
M Atiquzzaman, J Kopec, ME Karim, H Wong, A Anis
Annals of the Rheumatic Diseases 77 (Suppl 2), 144-144, 2018
|Causal inference approaches for dealing with time-dependent confounding in longitudinal studies, with applications to multiple sclerosis research|
University of British Columbia, 2015
|The randomization-induced risk of a trial failing to attain its target power: assessment and mitigation|
H Wong, Y Ouyang, ME Karim
Trials 20 (1), 360, 2019